Literature DB >> 24840262

Lipids and lipid management in diabetes.

Mamta Jaiswal1, Ashley Schinske2, Rodica Pop-Busui3.   

Abstract

Cardiovascular disease is more prevalent in type 1 and type 2 diabetes, and continues to be the leading cause of death among adults with diabetes. Although atherosclerotic vascular disease has a multi-factorial etiology, disorders of lipid metabolism play a central role. The coexistence of diabetes with other risk factors, in particular with dyslipidemia, further increases cardiovascular disease risk. A characteristic pattern, termed diabetic dyslipidemia, consists of increased levels of triglycerides, low levels of high density lipoprotein cholesterol, and postprandial lipemia, and is mostly seen in patients with type 2 diabetes or metabolic syndrome. This review summarizes the trends in the prevalence of lipid disorders in diabetes, advances in the mechanisms contributing to diabetic dyslipidemia, and current evidence regarding appropriate therapeutic recommendations.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cardiovascular disease; dyslipidemia; fibrates; lifestyle intervention; statins; type 1 diabetes; type 2 diabetes

Mesh:

Substances:

Year:  2013        PMID: 24840262     DOI: 10.1016/j.beem.2013.12.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  21 in total

1.  Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.

Authors:  Jian-Yu E; Shou-En Lu; Yong Lin; Judith M Graber; David Rotter; Lanjing Zhang; Gloria M Petersen; Kitaw Demissie; Grace Lu-Yao; Xiang-Lin Tan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-15       Impact factor: 4.254

Review 2.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

3.  Impact of different dietary approaches on blood lipid control in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis.

Authors:  Manuela Neuenschwander; Georg Hoffmann; Lukas Schwingshackl; Sabrina Schlesinger
Journal:  Eur J Epidemiol       Date:  2019-06-14       Impact factor: 8.082

Review 4.  Cardiovascular disease in type 1 diabetes.

Authors:  Harish Sharma; Mauro Lencioni; Parth Narendran
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-02-13

5.  Vitamin D₃ prevents the increase in ectonucleotidase activities and ameliorates lipid profile in type 1 diabetic rats.

Authors:  Nicéia Spanholi Calgaroto; Pauline da Costa; Andréia Machado Cardoso; Luciane Belmonte Pereira; Juliano Marchi Vieira; Diéssica Dalenogare; Luana Paula Pelinson; Jucimara Baldissarelli; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2015-04-17       Impact factor: 3.396

6.  Atorvastatin ameliorates depressive behaviors and neuroinflammatory in streptozotocin-induced diabetic mice.

Authors:  Zhang Hai-Na; Yu Xu-Ben; Tang Cong-Rong; Cao Yan-Cheng; Yang Fan; Xu Lei-Mei; Sun Ruo-Lan; Wang Ye-Xuan; Liang Jing
Journal:  Psychopharmacology (Berl)       Date:  2019-11-30       Impact factor: 4.530

7.  Risk Factors for Cardiovascular Disease in Type 1 Diabetes.

Authors: 
Journal:  Diabetes       Date:  2016-02-19       Impact factor: 9.461

8.  High fat diet dysregulates microRNA-17-5p and triggers retinal inflammation: Role of endoplasmic-reticulum-stress.

Authors:  Maha Coucha; Islam N Mohamed; Sally L Elshaer; Osinakachuk Mbata; Megan L Bartasis; Azza B El-Remessy
Journal:  World J Diabetes       Date:  2017-02-15

Review 9.  Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care.

Authors:  Jacob C Hartz; Sarah de Ferranti; Samuel Gidding
Journal:  J Endocr Soc       Date:  2018-05-01

Review 10.  Atorvastatin Treatment for Carotid Intima-Media Thickness in Chinese Patients With Type 2 Diabetes: A Meta-Analysis.

Authors:  Na Fang; Wei Han; Dandan Gong; Yu Fan
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.